Ország: Malajzia
Nyelv: angol
Forrás: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
DIGOXIN
Aspen Medical Products Malaysia Sdn Bhd
DIGOXIN
60 ml
Aspen Bad Oldesloe GmbH
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ _ _ 1 LANOXIN PG ELIXIR Digoxin (50mcg/ml) WHAT IS IN THE LEAFLET 1. What Lanoxin PG Elixir is used for 2. How Lanoxin PG Elixir works 3. Before you use Lanoxin PG Elixir 4. How to use Lanoxin PG Elixir 5. While you are using it 6. Side effects 7. Storage and Disposal of Lanoxin PG Elixir 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision 11. Serial number WHAT LANOXIN PG ELIXIR IS USED FOR Lanoxin PG Elixir is used to treat arrhythmias and heart failure. An arrhythmia is an irregularity in the heartbeat, which causes the heart to skip a beat, beat irregularly or beat at the wrong speed. HOW LANOXIN PG ELIXIR WORKS Lanoxin PG Elixir contains the active ingredient digoxin which belongs to a group of medicines called cardiac glycosides. Lanoxin PG Elixir works by correcting irregular heartbeats to a normal rhythm and strengthens the force of the heartbeat, which is why it is useful in heart failure. BEFORE YOU USE LANOXIN PG ELIXIR - _When you must not use it _ You must not take Lanoxin PG Elixir if you are allergic to digoxin, to other cardiac glycosides or to any of the other ingredients in this medicine. Lanoxin PG Elixir must not be used in patients with certain heart problems. Your doctor will have checked your medical history before treating you with this medicine. If you have any concerns you should discuss these with your doctor. - _Before you start to use it _ If you are pregnant or are intending to become pregnant or breastfeeding you must discuss this with your doctor. Your doctor will discuss the possible risks and benefits involved. - _Taking other medicines _ You MUST tell your doctor or pharmacist about all the medicines you are taking, even those which you have bought for yourself without a doctor's prescription, including herbal remedies such as St John's wort and vitamins. Digoxin interacts with lots of different medicines. The other medicines that you may be taking may increase or decrease the effect of La Olvassa el a teljes dokumentumot
1 LANOXIN QUALITATIVE AND QUANTITATIVE COMPOSITION Lanoxin PG Elixir contains the active ingredient Digoxin, 50mcg in 1 ml. PHARMACEUTICAL FORM Lanoxin PG Elixir is a clear, yellow, lime-flavoured solution containing 50mcg (0.050mg) Digoxin BP in each 1ml of sweetened, aqueous-alcoholic vehicle. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS CARDIAC FAILURE Digoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. Its therapeutic benefit is greatest in those patients with ventricular dilatation. Digoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. SUPRAVENTRICULAR ARRHYTHMIAS Digoxin is indicated in the management of certain supraventricular arrhythmias, particularly chronic atrial flutter and fibrillation. POSOLOGY AND METHOD OF ADMINISTRATION The dose of digoxin for each patient has to be tailored individually according to age, lean body weight and renal function. Suggested doses are intended only as an initial guide. The difference in bioavailability between injectable digoxin and oral formulations must be considered when changing from one dosage form to another. For example if patients are switched from oral to the intravenous formulation the dosage should be reduced by approximately 33%. Lanoxin PG Elixir, 50 mcg in 1 ml, is supplied with a graduated pipette and this should be used for measurement of all doses. 2 MONITORING Serum concentrations of digoxin may be expressed in Conventional Units of ng/ml or SI Units of nmol/l. To convert ng/ml to nmol/l, multiply ng/ml by 1.28. The serum concentration of digoxin can be determined by radioimmunoassay. Blood should be taken 6 hours or more after the last dose of digoxin. There are no rigid guidelines as to the range of serum concentrations that are most efficacious. Several _post hoc_ analyses of heart failure patients in the Digitalis Investigation Group trial demonstrated that at low serum digoxin concentrations (0.5 – 0.9 ng/ml), the use of digoxin was associ Olvassa el a teljes dokumentumot